World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
23796
World Ranking
19055
National Ranking
806

Overview

Georg A. Bjarnason is affiliated with Sunnybrook Health Science Centre in Canada. Their research focuses primarily on renal cell carcinoma treatment, cancer genomics and diagnostics, and related oncological fields. Their body of work spans the disciplines of Medicine, Biochemistry, Genetics and Molecular Biology, with notable contributions in pulmonary and respiratory medicine, oncology, cancer research, molecular biology, and surgery.

Their main research topics include:

  • Renal cell carcinoma treatment
  • Cancer genomics and diagnostics
  • Renal and related cancers
  • Cancer immunotherapy and biomarkers
  • Bladder and urothelial cancer treatments
  • Economic and financial impacts of cancer
  • Pancreatic and hepatic oncology research

Georg A. Bjarnason has authored numerous publications in reputable venues. Their most frequent publication venues are:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • Clinical Genitourinary Cancer
  • European Urology
  • Canadian Urological Association Journal

Their recent publications include:

  • Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma, 2021, Journal of Clinical Oncology
  • A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial, 2021, The Lancet
  • Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival, 2021, JAMA Network Open
  • Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma, 2023, Journal of Clinical Oncology
  • Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma, 2021, Journal of Clinical Oncology

Collaboration plays an important role in the scientist's work. Frequent co-authors include:

  • Lori Wood
  • Naveen S. Basappa
  • Aly-Khan A. Lalani
  • Rodney H. Breau
  • Frédéric Pouliot

Their research integrates both clinical and molecular study approaches, contributing to the understanding and treatment of renal and related cancers. The focus on immunotherapy and biomarkers is evident in several recent studies involving therapeutic interventions and survival outcomes.

Best Publications

  • Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Thomas E. Hutson;Piotr Tomczak;M. Dror Michaelson

  • Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

    John M.L. Ebos;Christina R. Lee;William Cruz-Munoz;Georg A. Bjarnason

  • Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

    Toni K. Choueiri;Bernard Escudier;Thomas Powles;Paul N. Mainwaring

  • External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

    Daniel Y.C. Heng;Wanling Xie;Meredith M. Regan;Lauren C. Harshman

  • Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

    Martin E Gore;Cezary Szczylik;Camillo Porta;Sergio Bracarda

  • Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases.

    Georg A. Bjarnason;Richard C.K. Jordan;Richard C.K. Jordan;Patricia A. Wood;Qi Li

  • Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

    Daniel Y.C. Heng;J. Connor Wells;Brian I. Rini;Benoit Beuselinck

  • Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma

    Thomas E. Hutson;Bernard Escudier;Emilio Esteban;Georg A. Bjarnason

  • The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

    Jenny J. Ko;Wanling Xie;Nils Kroeger;Jae lyun Lee

  • Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial

    Robert John Motzer;Camillo Porta;Nicholas J Vogelzang;Cora N Sternberg

  • Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

    Sylvie Giacchetti;Georg Bjarnason;Carlo Garufi;Dominique Genet

  • Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

    Nils Kroeger;Wanling Xie;Jae Lyn Lee;Georg A. Bjarnason

  • Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy.

    Rana R. McKay;Nils Kroeger;Nils Kroeger;Wanling Xie;Jae Lyun Lee

  • Circadian Variation in the Expression of Cell-Cycle Proteins in Human Oral Epithelium

    Georg A. Bjarnason;Richard C.K. Jordan;Richard C.K. Jordan;Robert B. Sothern

  • Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer

    Pasquale F Innominato;Christian Focan;Thierry Gorlia;Thierry Moreau

  • miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation

    Nicole M.A. White;Nicole M.A. White;Tian Tian Bao;Jörg Grigull;Youssef M. Youssef

  • Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma.

    David F McDermott;Jae-Lyun Lee;Marek Ziobro;Cristina Suarez

  • Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

    Laurence Albiges;Laurence Albiges;A. Ari Hakimi;Wanling Xie;Rana R. McKay

  • A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

    Sumanta K Pal;Catherine Tangen;Ian M Thompson;Naomi Balzer-Haas

  • Chronotherapy and the molecular clock: Clinical implications in oncology

    Pasquale F. Innominato;Francis A. Lévi;Georg A. Bjarnason

Frequent Co-Authors

Toni K. Choueiri
Toni K. Choueiri Harvard University
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Christian Kollmannsberger
Christian Kollmannsberger University of British Columbia
Sun Young Rha
Sun Young Rha Yonsei University
George M. Yousef
George M. Yousef University of Toronto
Ulka N. Vaishampayan
Ulka N. Vaishampayan University of Michigan–Ann Arbor
Antonio Finelli
Antonio Finelli University Health Network
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Michael A.S. Jewett
Michael A.S. Jewett University of Toronto
Camillo Porta
Camillo Porta University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of healthcare careers, some of which can be pursued online. These online programs offer flexibility for students balancing work and family commitments.

For those interested in the technology side of healthcare, health information technology programs online provide critical skills for managing medical data and supporting patient care. If you’re detail-oriented and enjoy administrative work, medical billing and coding online courses can prepare you for essential roles within hospitals, clinics, and insurance companies.

Aspiring nurses have more options than ever before, with online nurse practitioner programs helping qualified candidates move into advanced clinical roles. There are also pathways to become a registered nurse through an nursing degree online, making it easier to start or progress a rewarding career in patient care.

These online healthcare degrees and certificates are shaping the future of medical education, broadening access to vital, in-demand professions across the country.

Best Scientists Citing Georg A. Bjarnason

Trending Scientists

Recently Published Articles